12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Amarantus BioSciences Inc., Rainbow Coral deal

Amarantus and Rainbow Coral's Rainbow BioSciences LLC subsidiary formed a revenue-sharing JV to develop Amarantus' NuroPro diagnostic blood test for the early detection of Parkinson's disease. In April, the parties signed a letter of intent to...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >